OClawVPS.com
Edit

BioImpact Capital

https://bioimpactcapital.com
Last activity: 02.05.2023
Probably Closed
Invests in categories: ProductPlatformResearchBioTechDevelopmentTechnologyDrugMedtechHumanHealthTech
News
17
Portfolio
12

Portfolio 12

DateNameWebsiteTotal RaisedLocation
-Oncorusoncorus.com$141.99MUnited Sta...
-Cullinan O...cullinanoncology.com$379.7MUnited Sta...
-Werewolf T...werewolftx.com$128MUnited Sta...
-Twentyeigh...twentyeight-seven.com$80M-
-Harpoon Th...harpoontx.com$201.25MUnited Sta...
-TCR² Thera...tcr2.com$125MUnited Sta...
-Aktis Onco...aktisoncology.com$331M-
-Repare The...reparerx.com$150.5MCanada
-Orna Thera...ornatx.com$321MUnited Sta...
-iTeos Ther...iteostherapeutics.com$339.83MUnited Sta...
Show more

News 17

DateTitleDescription
10.01.2023NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs-
22.09.2022Orna Therapeutics named to the Endpoints 11: The top private biotechs in pursuit of new drugs.-
25.08.2022Aktis Oncology Raises $84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals-
16.08.2022Orna goes into orbit on $3.65B Merck megadeal, $221M series B round-
16.08.2022BioImpact Capital Announces a Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer-
16.08.2022Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform and Accelerate Programs to the Clinic-
05.08.2022Orna Therapeutics: circular logic-
02.06.2022BioImpact Capital’s Christiana Bardon: GBR Interview-
08.03.2022AACR and BioImpact Capital Announce Two Grants to Support Transformative Cancer Research-
19.10.2021Future Returns: BioImpact Capital’s Second Oncology Impact Fund Goes Beyond Cancer-
Show more

Reviews 0

Sign up to leave a review

Sign up Log In